Отображение 1 - 5 результаты of 5 для поиска 'F. Zaja', время запроса: 0.02сек. Отмена результатов
  1. 1
    P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS

    P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS по W. Ghanima, F. Zaja, J. Maier, J. Haenig, J. Lee, N. Cooper

    Опубликовано 2022-06-01
    Полный текст
    Статья
  2. 2
    S292: SUSTAINED RESPONSE OFF TREATMENT IN ELTROMBOPAG-TREATED PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE STEROIDS: PRIMARY ANALYSIS OF THE PHASE II TAPER TRIAL

    S292: SUSTAINED RESPONSE OFF TREATMENT IN ELTROMBOPAG-TREATED PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE STEROIDS: PRIMARY ANALYSIS OF THE PHASE II TAPER TRI... по N. Cooper, W. Ghanima, N. Vianelli, D. Valcárcel, I. Yavaşoğlu, A. Melikyan, E. Yañez Ruiz, J. Haenig, J. Lee, J. Maier, N. Zolkin, F. Zaja

    Опубликовано 2022-06-01
    Полный текст
    Статья
  3. 3
    S136: CONSTITUTIVE VLA-4 ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. THE OTHER SIDE OF BCR AUTONOMOUS SIGNALING.

    S136: CONSTITUTIVE VLA-4 ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA. THE OTHER SIDE OF BCR AUTONOMOUS SIGNALING. по E. Tissino, R. Bomben, P. C. Maity, F. Pozzo, G. Forestieri, A. Nicolò, A. Härzschel, T. Bittolo, F. M. Rossi, M. Datta, F. Zaja, G. Capasso, G. D’Arena, A. Chiarenza, F. Di Raimondo, H. Jumaa, D. Rossi, G. Del Poeta, T. N. Hartmann, A. Zucchetto, V. Gattei

    Опубликовано 2022-06-01
    Полный текст
    Статья
  4. 4
    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE

    P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE по R. Bomben, F. M. Rossi, F. Vit, T. Bittolo, A. Zucchetto, R. Papotti, E. Tissino, F. Pozzo, M. Degan, E. Zaina, I. Cattarossi, P. Nanni, R. Marasca, G. Reda, L. Laurenti, J. Olivieri, A. Chiarenza, L. Ballotta, A. Cuneo, M. Gentile, F. Morabito, A. Tafuri, F. Zaja, R. Foà, F. Di Raimondo, G. Del Poeta, V. Gattei

    Опубликовано 2022-06-01
    Полный текст
    Статья
  5. 5
    PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA

    PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA по M. E. Mingot Castellano, C. A. Bradbury, C. Rosso Fernández, I. Thomas, M. T. Alvarez-Román, M. Canaro, I. S. Caparrós Miranda, M. Cappechi, M. Carpenedo, G. Evans, J. T. González-Lopéz, J. R. González-Porras, I. Jarque Ramos, M. L. Lozano-Almela, M. F. Lopez Fernandez, G. Lowe, H. Lyall, C. Pascual Izquierdo, S. Pavord, R. Rayment, P. Roberts, P. Rosique Cortina, B. Sánchez-González, C. Santoro, K. Talks, D. Valcarcel-Ferreiras, F. Zaja

    Опубликовано 2022-06-01
    Полный текст
    Статья

Инструменты поиска: